Company Search:
Advanced Search
Sponsored Links
Paradigm Biopharmaceuticals Ltd Company Snapshot
Paradigm Biopharmaceuticals Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Paradigm Biopharmaceuticals Ltd with three other companies in this sector in AUSTRALIA : Creso Pharma Ltd (2019 sales of 3.68 million Australian Dollars [US$2.57 million] ), Adalta Ltd (3.59 million Australian Dollars [US$2.50 million] ), and Noxopharm Ltd (3.94 million Australian Dollars [US$2.75 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Paradigm Biopharmaceuticals Ltd
  Stock Performance Chart for Paradigm Biopharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 3.41
(Figures in Australian Dollars)
1 Week 0.6%   13 Weeks 11.1%  
4 Weeks 101.8%   52 Weeks 124.3%  
Paradigm Biopharmaceuticals Ltd Key Data:
  Ticker: PAR Country: Australia
  Exchanges: ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 3,245,628
(Year Ending Jan 2020).
Employees: N/A
  Currency: Australian Dollars Market Cap: 671,425,928
  Fiscal Yr Ends: June Shares Outstanding: 196,899,099
  Share Type: Ordinary Closely Held Shares: 46,781,526
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.